1. Home
  2. DNN vs TARS Comparison

DNN vs TARS Comparison

Compare DNN & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denison Mines Corp (Canada)

DNN

Denison Mines Corp (Canada)

HOLD

Current Price

$3.08

Market Cap

2.9B

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$58.58

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNN
TARS
Founded
1954
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Medicinal Chemicals and Botanical Products
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.7B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
DNN
TARS
Price
$3.08
$58.58
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$6.50
$89.00
AVG Volume (30 Days)
25.5M
1.2M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.21
EPS
N/A
N/A
Revenue
N/A
$451,360,000.00
Revenue This Year
$403.36
$56.43
Revenue Next Year
N/A
$30.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
146.71
52 Week Low
$1.86
$38.51
52 Week High
$4.43
$85.25

Technical Indicators

Market Signals
Indicator
DNN
TARS
Relative Strength Index (RSI) 46.27 41.83
Support Level $2.56 $56.05
Resistance Level $3.39 $67.14
Average True Range (ATR) 0.14 3.50
MACD -0.00 -0.61
Stochastic Oscillator 43.33 14.43

Price Performance

Historical Comparison
DNN
TARS

About DNN Denison Mines Corp (Canada)

Denison Mines Corp is engaged in uranium mining-related activities, including the acquisition, exploration, development, and mining of uranium-bearing properties, as well as the processing, sale, and investment in uranium. The company's key properties include Wheeler River, Waterbury Lake, McClean Lake, Midwest, and others. It operates through two segments: the Mining segment and the Corporate and Other segment. The majority of the company's revenue is generated from the Mining segment, which includes activities related to exploration, evaluation, and development, mining, milling (including toll milling), and the sale of mineral concentrates.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: